T. Imamoto et al. / Tetrahedron: Asymmetry 15 (2004) 2213–2218
2217
(c 1.01, CHCl3). This compound corresponds to (S)-2.
1H NMR (400 MHz, CDCl3): d 1.17 (d, 3JHP 16 Hz, 9H),
3.38–3.58 (m, 2H), 7.30–7.43 (m, 2H), 7.47–7.57 (m,
2H); 13C NMR (100 MHz, CDCl3): d 24.16 (d, JCP
1.7 Hz), 33.18 (d, JCP 56.6 Hz), 36.12(d, JCP 56.6 Hz),
125.59 (d, JCP 25.4 Hz), 127.20, 128.54 (d, JCP 12.4 Hz),
133.91 (d, JCP 3.3 Hz), 141.31 (d, JCP 24.6 Hz), 141.73 (d,
JCP 42.6 Hz); IR (KBr): 3060, 2950, 2900, 2860, 1960,
1920, 1590, 1450 cmÀ1; IR (KBr): 3060, 2950, 2900,
2860, 1960, 1920, 1590, 1450 cmÀ1. Anal. Calcd for
C11H15PO: C, 68.03, H, 7.78. Found: C, 68.13; H, 8.01.
144.76 (m); IR (KBr) 2950, 2860, 2360, 1590, 1480, 1450,
1190 cmÀ1
.
4.5. dl-1,10-Di-tert-butyl-2,20-dibenzophosphetanyl
dioxide dl-3
Compound dl-2 was treated subsequently with s-BuLi
and copper(II) chloride to produce dl-3 and meso-isomer
in 83:17 ratio. Pure dl-3 was obtained by chromatogra-
phy on silica gel using EtOAc as the eluent. Mp 180 ꢁC
3
(decomp.). 1H NMR (100 MHz, CDCl3): d 1.23 (d, JHP
The compound with late retention time: mp 39–41 ꢁC,
1
17
15.9 Hz, 18H), 4.46 (d, JHP 4.1 Hz, 2H), 7.31–7.39 (m,
99.0% ee, ½a ¼ þ21:7 (c 0.98, CHCl3). This compound
D
2H), 7.41–7.52 (m, 6H); 13C NMR (100 MHz, CDCl3): d
24.12, 33.22–33.98 (m), 46.38–47.20 (m), 126.91–127.16
1
corresponds to (R)-2. H NMR (400 MHz, CDCl3): d
3
1.18 (d, JHP 16 Hz, 9H), 3.38–3.58 (m, 2H), 7.30–7.43
(m, 2H), 7.47–7.57 (m, 2H); 13C NMR (100 MHz,
CDCl3): d 24.09 (d, JCP 1.6 Hz), 33.61 (d, JCP 56.6 Hz),
36.05 (d, JCP 56.6 Hz), 125.53 (d, JCP 26.2 Hz), 127.13,
128.48 (d, JCP 11.5 Hz), 133.86 (d, JCP 3.3 Hz), 141.31 (d,
JCP 26.2 Hz), 141.65 (d, JCP 40.2Hz).
(m), 129.05–129.16 (m), 133.77, 140.79–141.61 (m, 2C),
31
144.72–144.76 (m);
60.95. IR (KBr): 2950, 2860, 2360, 1590, 1480, 1450,
P NMR (202 MHz, CDCl3): d
1190 cmÀ1
.
4.6. Optical resolution of dl-3
4.4. (1S,10S,2R,20R)-1,10-di-tert-butyl-2,20-dibenzo-
phosphetenyl dioxide (S,S)-3 and (1R,10R,2S,20S)-1,10-di-
tert-butyl-2,20-dibenzophosphetenyl dioxide (R,R)-3
A mixture of dl-3 (38.6 mg, 0.1 mmol) and (2S,3S)-
(þ)-O,O0-dibenzoyltartaric acid [(þ)-DBTA; 179 mg,
0.5 mmol] was dissolved in hot ethyl acetate (1 mL). The
mixture was gradually cooled to room temperature. The
precipitated crystalline solid was collected by filtration,
washed with ethyl acetate, treated with 1 M NaOH
(2mL). The mixture was extracted with chloroform,
dried over Na2SO4 and concentrated under reduced
pressure to give (S,S)-3 (8.1 mg) as a white powder.
Enantiomeric excess of this product was determined to
be 98.8% by HPLC analysis (Chiralcel OD-H, 0.5 mL,
25 ꢁC, 2-propanol/hexane (1:19), (S,S) t1 ¼ 16:9 min,
(R,R) t2 ¼ 23:3 min, (meso) t3 ¼ 25:3 min).
s-Butyllithium (0.97 M in cyclohexane, 2.9 mL,
2.8 mmol) was added over 5 min to a solution of
N,N,N0,N0-tetramethylethylenediamine (0.42mL, 2.8
mmol) in dry THF (2mL) at À78 ꢁC under argon. After
30 min, a solution of (S)-2 (500 mg, 2.57 mmol) in dry
THF (3 mL) was added dropwise. The bright red mix-
ture was stirred at this temperature for 2h then À50 ꢁC
for 2h. Dry copper(II) chloride (dried at 120–130 ꢁC for
4 h in vacuo, 450 mg, 3.34 mmol) was added in one
portion with vigorous stirring and the mixture then
gradually warmed to room temperature overnight.
Aqueous ammonia (25%, 5 mL) was added and the
layers separated. The aqueous layer was extracted with
ethyl acetate (2 · 10 mL). The combined organic layers
were washed with 1 M HCl, water, and brine and dried
over Na2SO4. The solvents were removed under reduced
pressure and the residual (a yellow solid) was washed
with a small amount of ethyl acetate (ca. 4 mL) to give
4.7. X-ray crystallographic analysis of (S,S)-3
A well shaped orthorhombic crystal of (S,S)-3 was
obtained by recrystallization from ethyl acetate. A col-
ourless prism crystal of C22H28O2P2 having approxi-
mate dimensions of 0.40 · 0.30 · 0.20 mm was mounted
in a glass capillary. All measurements were made on a
Rigaku RAXIS-II Imaging Plate diffractometer
with graphite monochromated Mo Ka radiation
(S,S)-3 (220 mg, 44%). Mp 180 ꢁC (decomp); Rf 0.11
19
(EtOAc); ½a ¼ À12:3 (c 1.00, CHCl3); 1H NMR
D
3
(400 MHz, CDCl3): d 1.23 (d, JHP 16Hz, 18H), 4.46 (d,
ꢁ
(k ¼ 0:71070 A) at 173 K. Crystal data and refinement
1JHP 4 Hz, 2H), 7.31–7.39 (m, 2H), 7.41–7.52 (m, 6H);
13C NMR (100 MHz, CDCl3): d 24.11, 33.22–33.98 (m),
46.38–47.20 (m), 126.91–127.16 (m), 129.05–129.16 (m),
133.77, 140.79–141.61 (m, 2C), 144.72–144.76 (m); IR
ꢁ
details: space group P212121 (#19); a ¼ 9:722ð7Þ A,
3
ꢁ
ꢁ
ꢁ
b ¼ 22:91ð2Þ A, c ¼ 9; 65ð1Þ A; V ¼ 2149ð3Þ A ; Z ¼ 4,
Dcalcd ¼ 1:194 g/cm3;
F ð000Þ ¼ 824;
l(Mo Ka) ¼
2.15 cmÀ1; 1790 reflections measured, 1654 observed
(I > 2:00rðIÞ); 235 variables; R ¼ 0:072, Rw ¼ 0:079,
GOF ¼ 1.40. The absolute configuration was determined
by the Flack parameter method. Cambridge Crystallo-
graphic Data Centre supplementary publication number
CCDC 240727.
(KBr) 2950, 2860, 2360, 1590, 1480, 1450, 1190 cmÀ1
.
Anal. Calcd for C22H28O2P2: C, 68.38; H, 7.30. Found:
C, 68.10; H, 7.49.
In a similar manner, (R)-2 was converted to (R,R)-3
in 45% yield. Mp 180 ꢁC (decomp); Rf 0.11
19
(EtOAc); ½a ¼ þ12:5 (c 0.97, CHCl3); 1H NMR
D
3
(400 MHz, CDCl3): d 1.23 (d, JHP 16 Hz, 18H), 4.45
4.8. Reduction of bis(tert-butylbenzophosphetane)oxide
and preparation of rhodium complex
1
(d, JHP 4 Hz, 2H), 7.32–7.40 (m, 2H), 7.41–7.52
(m, 6H); 13C NMR (100 MHz, CDCl3): d 24.11, 33.21–
33.97 (m), 46.38–47.20 (m), 126.91–127.16 (m), 129.04–
129.16 (m), 133.76, 140.79–141.70 (m, 2C), 144.71–
Hexachlorodisilane (70 lL, 0.39 mmol) was added drop-
wise to a solution of (R,R)-3 (50 mg, 0.13 mmol) in dry,